<%
  dim title, heading, subtitle
  heading = "External Publications"
  subtitle = "Cancer"
%>
<!-- #include virtual = "/_inc/head.asp" -->

<div class="container">
  <div class="row">&nbsp;</div>
</div>

<div class="container">
  <div class="row">

    <div class="col-md-2">
    <!-- #include virtual = "/_inc/nav-topic.asp" -->
    <!-- #include virtual = "health-topics/cancer/_inc/nav-sub-topic.asp" -->
    </div>

    <div id="content" class="col-md-10">
      <!-- Content -->

      <h2>External Publications</h2>

 <p> <strong>Publications 2000-2011,  members of staff </strong></p>
 <h3>Books/Reports or Chapters in Books/Reports</h3>
 <p><strong>2000</strong></p>
<p>Information &amp; Statistics Division. Cancer. In: <em>Scottish Health Statistics</em> 1999. (pp 73-93) Edinburgh: ISD Scotland Publications, 2000.</p>
 <p>Mi&#241;arro R, Black RJ, Mart&#237;nez C, Navarro C, Garau I, Izarzugaza I, Ardanaz E, Vergara A, Galcer&#225;n J, Alonso R, Mateos A, Rodr&#237;guez M (eds). <em>Cancer Incidence and Mortality in Spain</em>. IARC Technical Report No. 36. Lyon: International Agency for Research on Cancer, 2000.</p>
 <p>Scottish Cancer Intelligence Unit. Trends in Cancer Survival in Scotland 1971 - 1995. Edinburgh: Information &amp; Statistics Division, 2000.</p>
 <p><strong>2001</strong></p>
<p>McCann J, Stockton D. Screening evaluation and monitoring: some practical considerations. In: Duffy S, Hill C, Est&#232;ve J (eds). <em>Cancer Screening &#8211;  Methods of Quantitive Evaluation</em>. London: Arnold Publishers, 2001, pp 81-92. </p>
 <p>Scottish Executive Health Department. <em>Cancer Scenarios: An aid to planning cancer services in Scotland in the next decade</em>. Edinburgh: The Scottish Executive, 2001.</p>
 <p>Stockton D, McCann J. Breast cancer-selected examples. In: Sankila R, D&#233;maret E, Hakama M, Lynge E, Schouten L, Parkin DM (eds). <em>Evaluation and Monitoring of Screening Programmes</em>. Brussels-Luxembourg: European Commission, 2001, pp 181-194.</p>
 <p>Stockton D. <em>Cancer Survival in Scotland - Understanding Social Variations</em> (PhD Thesis). London: London School of Hygiene and Tropical Medicine, 2001.</p>
 <p><strong>2002</strong></p>
<p>Brewster D, Harkness E, Harvey J, Kidd J, Black R. UK, Scotland. In: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds). <em>Cancer Incidence in Five Continents</em> (volume VIII). IARC Scientific Publications No. 155. Lyon: International Agency for Research on Cancer, 2002.</p>
 <p><strong>2003</strong></p>
<p>Black R, Stockton D, Brewster D. Scenario planning using cancer incidence and mortality projections. In: Sankila R, Black R, Coebergh JW, D&#233;maret E, Forman D, Gatta G, Parkin DM (eds). <em>Evaluation of Clinical Care by Cancer Registries</em>. (pp 47-50). IARC Technical Report No. 37. Lyon: International Agency for Research on Cancer, 2003.</p>
 <p>Brewster D, Gregor A. Cancer in Scotland. In: Woods K, Carter D (eds). <em>Scotland&#39;s Health and Health Services</em>. Nuffield Trust for Research and Policy Studies in Health Services. London: The Stationery Office, 2003.</p>
 <p>Sankila R, Black R, Coebergh JW, D&#233;maret E, Forman D, Gatta G, Parkin DM (eds). <em>Evaluation of Clinical Care by Cancer Registries</em>. IARC Technical Publication No. 37. Lyon: International Agency for Research on Cancer, 2003.</p>
 <p><strong>2004</strong></p>
<p>Campbell J, Wallace WHB, Bhatti LA, Stockton DL, Rapson T, Brewster DH. <em>Childhood Cancer in Scotland: Trends in Incidence, Mortality, and Survival, 1975-1999</em>. Edinburgh: Information &amp; Statistics Division, 2004.</p>
 <p><strong>2005</strong></p>
<p>Brewster D, M&#248;ller H. Larynx. In: Quinn M, Wood H, Cooper N, Rowan S (eds). <em>Cancer Atlas of the United Kingdom and Ireland 1991-2000</em>. ONS SMPS No. 68. Basingstoke: Palgrave MacMillan, 2005.</p>
 <p>M&#248;ller H, Brewster D. Lip, mouth and pharynx. In: Quinn M, Wood H, Cooper N, Rowan S (eds). <em>Cancer Atlas of the United Kingdom and Ireland 1991-2000</em>. ONS SMPS No. 68. Basingstoke: Palgrave MacMillan, 2005.</p>
 <p>Rowan S, Brewster D. Colorectal. In: Quinn M, Wood H, Cooper N, Rowan S (eds). <em>Cancer Atlas of the United Kingdom and Ireland 1991-2000</em>. ONS SMPS No. 68. Basingstoke: Palgrave MacMillan, 2005.</p>
 <p>Wood H, Brewster D, M&#248;ller H. Oesophagus. In: Quinn M, Wood H, Cooper N, Rowan S (eds). <em>Cancer Atlas of the United Kingdom and Ireland 1991-2000</em>. ONS SMPS No. 68. Basingstoke: Palgrave MacMillan, 2005. </p>
 <p><strong>2007</strong></p>
<p>Brewster D, Bhatti L, McDonald A, Stark J, Black R. <em>Cancer Incidence in Scotland (1998-2002)</em>. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (eds). <em>Cancer Incidence in Five Continents</em> (volume IX). IARC Scientific Publications No. 160. Lyon: International Agency for Research on Cancer, 2007.</p>
 <h3>Papers and letters in journals</h3>
<p><strong>2000</strong></p>
<p>Brewster DH, Fraser LA, Harris V, Black RJ. Rising incidence of prostate cancer in Scotland: increased risk or increased detection? <em>BJU Int</em> 2000; 85: 463-472.</p>
 <p>Brewster DH, Fraser LA, McKinney PA, Black RJ. Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland. <em>Br J Cancer</em> 2000; 83: 387-390.<br />
 <br />
 Cheng KK, Sharp L, McKinney PA, Logan RFA, Chilvers CED, Cook Mozaffari P, Ahmed A, Day NE. A case-control study of oesophageal adenocarcinoma in women: a preventable disease. <em>Br J Cancer</em> 2000; 83: 127-132.</p>
 <p>Coleman MP, Babb P, Stockton D, Forman D, Moller H. Correspondence. <em>Lancet</em> 2000; 35: 590-591. </p>
 <p>Coleman MP, Stockton D, Babb P, Richards M. Survival and reduction in mortality from breast cancer (letter). <em>BMJ</em> 2000; 321: 1471-1472.</p>
 <p>Richards MA, Stockton D, Babb P, Coleman MP. How many deaths have been avoided through improvements in cancer survival? <em>BMJ</em> 2000; 320: 895-898.</p>
 <p>The UK Childhood Cancer Study Investigators. Childhood Cancer and Residential Proximity to Power Lines. <em>Br J Cancer</em> 2000; 83: 1573-1580.</p>
 <p>Thomas E, Brewster DH, Black RJ, Macfarlane GJ. The Risk of Malignancy Amongst Patients with Rheumatic Conditions. <em>Int J Cancer</em> 2000; 88: 497-502.</p>
 <p>UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study: objectives, materials and methods. <em>Br J Cancer</em> 2000; 82: 1073-1102.</p>
 <p><strong>2001</strong></p>
<p>Brewster DH, Coleman MP, Forman D, Roche M. Cancer information under threat: the case for legislation<em>. Ann Oncol</em> 2001; 12: 145-147.</p>
 <p>Brewster DH, Thomson CS, Hole DJ, Black RJ, Stroner PL, Gillis CR, on behalf of the Scottish Cancer Therapy Network. Relationship between socioeconomic status and tumour stage in breast, colorectal, ovarian, and lung cancer patients: results from four national, population-based studies. <em>BMJ</em> 2001; 322: 830-831.</p>
 <p>Cull A, Gould A, House A, Smith A, Strong V, Velikova G, Wright P, Selby P. Validated automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. <em>Br J Cancer</em> 2001; 85: 1842-1849.</p>
 <p>Cull A, Howat S, Greimel E, Waldenstrom AC, Arraras J, Kudelka A, Chauvenet L, Gould A. EORTC Quality of Life Group [European Organization for Research and Treatment of Cancer]. Scottish Gynaecological Cancer Trials Group. Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report. <em>Eur J Cancer</em> 2001; 37: 47-53. </p>
 <p>Forman D, Roche M, Coleman M, Brewster D. Monitoring of cancer risks and survival rates requires information on all cancer patients. <em>Br J Healthcare Comput Info Manage</em> 2001; 18: 24-26.</p>
 <p>Gregor A, Thomson CS, Brewster DH, Stroner PL, Davidson J, Fergusson RJ, Milroy R, on behalf of the Scottish Cancer Trials Lung Group and the Scottish Cancer Therapy Network. Management and survival of lung cancer patients diagnosed in 1995 in Scotland: results of a national, population-based study. <em>Thorax</em> 2001; 56: 212-217.</p>
 <p>Howard GCW, Thomson CS, Stroner PL, Goodman CM, Windsor PM, Brewster DH. Patterns of referral, management and survival of patients diagnosed with prostate cancer in Scotland during 1988 and 1993: results of a national, retrospective population-based audit. <em>BJU Int</em> 2001; 87: 339-347.</p>
 <p>Sharp L, Chilvers CED, Cheng KK, McKinney PA, Logan RFA, Cook-Mozaffari, Ahmed A, Day NE. Risk factors for squamous cell carcinoma of the oesophagus in women: a case-control study. <em>Br J Cancer</em> 2001; 85: 1667-1670.</p>
 <p>Sorahan T, McKinney PA, Mann JR, Lancashire RJ, Stiller CA, Birch JM, Dodd HE, Cartwright RA. Childhood cancer and parental use of tobacco: findings from the inter-regional epidemiological study of childhood cancer (IRESCC). <em>Br J Cancer</em> 2001; 84: 141-146.</p>
 <p>Stockton D, Doherty V, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. <em>Br J Cancer</em> 2001; 85: 41-45.</p>
 <p>Thomson CS, Hole DJ, Twelves C, Brewster DH, Black RJ. Prognostic factors in women with breast cancer: distribution by socio-economic status and effect on differences in survival. <em>J Epidemiol Community Health</em> 2001; 55: 308-315.</p>
 <p>Twelves C, Thomson CS, Brewster DH, Dewar JA. Variation in survival of women with breast cancer: Health Board remains a factor at ten years. <em>Br J Cancer</em> 2001; 85: 637-640.</p>
 <p>Wright EP, Selby PJ, Gould A, Cull A. Detecting social problems in cancer patients. <em>Psycho-Oncol</em> 2001; 10: 242-250.</p>
 <p><strong>2002</strong></p>
<p>Brewster DH, Stockton D, Harvey J, Mackay M. Reliability of cancer registration data in Scotland, 1997. <em>Eur J Cancer</em> 2002; 38: 414-417.</p>
 <p>Erridge SC, Thomson CS, Davidson J, Jones RD, Price A, on behalf of the Scottish Cancer Trials Lung Group and the Scottish Cancer Therapy Network. Factors influencing the use of thoracic radiotherapy in lung cancer - an analysis of the 1995 Scottish lung cancer audit. <em>Clin Oncol </em>2002; 14: 219-227.</p>
 <p>Gray RF, Brewster DH, Kidd J, Burns H. Colorectal Cancer in Scotland: Recent Trends in Incidence and Mortality. <em>Gastrointestinal Oncology</em> 2002; 4: 213-222.</p>
 <p>Harkness EF, Brewster DH, Kerr KM, Fergusson RJ, MacFarlane GJ. Changing trends in incidence of lung cancer by histological type in Scotland. <em>Int J Cancer</em> 2002; 102: 179-183.</p>
 <p>Roman E, Fear NT, Ansell P, Bull D, Draper G, McKinney P, Michaelis J, Passmore SJ, von Kries R. Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies. <em>Br J Cancer</em> 2002; 86: 63-69.</p>
 <p>Smith AB, Selby PJ, Velikova G, Stark D, Wright EP, Gould A, Cull A. Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population.<em>Psychology and Psychotherapy: Theory, Research and Practice </em>2002; 75: 165-176.</p>
 <p><em>Thomson CS, Twelves CJ, Mallon EA, Leake RE.</em> Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status. <em>Breast</em><em>2002; 11: </em>419-429.</p>
 <p>UK Childhood Cancer Study Investigators (writing committee Law GR, Smith AG, Roman E). The importance of full participation: lessons from a national case-control study. <em>Br J Cancer</em> 2002; 86: 350-355.</p>
 <p>UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 1: radon gas. <em>Br J Cancer</em> 2002; 86: 1721-1726.</p>
 <p>UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 2: gamma radiation. <em>Br J Cancer</em> 2002; 86: 1727-1731.</p>
 <p><strong>2003</strong></p>
<p>Allardice GM, Hole D, Brewster D, Boyd J, Goldberg D. Incidence of malignant neoplasms among HIV infected persons in Scotland by HIV risk group. <em>Br J Cancer </em>2003; 83: 505-507.</p>
 <p>Anderson TJ, Davis C, Alexander FE, Dobson HM, on behalf of the Scottish Breast Pathology Coordination Group. Measures of benefit for breast screening from the pathology database for Scotland, 1991-2001. <em>J Clin Pathol</em> 2003; 56: 654-659.</p>
 <p>Fergusson RJ, Thomson CS, Brewster DH, Brown PH, Milroy R, on behalf of the Scottish Cancer Trials Lung Group and the Scottish Cancer Therapy Network. Lung Cancer in Scotland - Importance of Seeing a Respiratory Physician. <em>Eur Resp J</em> 2003; 21: 606&#8211; 610.</p>
 <p>Forman D, Stockton D, M&#248;ller H, Quinn M, Babb P, De Angelis R, Micheli A.&nbsp;Cancer prevalence in the UK: results from the EUROPREVAL Study. <em>Ann Oncol</em> 2003;14: 648&#8211; 654.</p>
 <p>McKenna DB, Stockton D, Brewster DH, Doherty VR. Evidence for an Association between Cutaneous Malignant Melanoma and Lymphoid Malignancy: a Population-based Retrospective Cohort Study in Scotland. <em>Br J Cancer </em>2003; 88: 74-78.</p>
 <p>McKinney PA, Fear NT, and Stockton D, on behalf of the UK Childhood Cancer Study Investigators. Parental occupation at periconception: findings from the United Kingdom Childhood Cancer Study. <em>Occup Environ Med</em> 2003; 50: 901-909.</p>
 <p>Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, Holub J, Storm HH, Forman D, Quinn M, Aareleid T, Sankila R, Hakulinen T, Faivre J, Ziegler H, Tryggvad&#242;ttir L, Zanetti R, Dalmas M, Visser O, Langmark F, Bielska-Lasota M, Wronkowski Z, Pinheiro PS, Brewster DH, Plesko I, Pompe-Kirn V, Martinez-Garcia C, Barlow L, M&#246;ller T, Lutz JM, Andr&#233; M, Steward JA. European health systems and cancer care. <em>Ann Oncol</em> 2003; 14 (supplement 5): v41-v60.</p>
 <p>Pang D, McNally R, Birch JM on behalf of the UK Childhood Cancer Study Investigators. Parental smoking and childhood cancer: results from the United Kingdom Childhood Cancer Study. <em>Br J Cancer </em>2003;88: 373-381. </p>
 <p>Quinn MJ, d'Onofrio A, M&#248;ller B, Black R, Martinez-Garcia C, M&#248;ller H, Rahu M, Robertson C, Schouten LJ, La Vecchia C, Boyle P. Cancer mortality trends in the EU and acceding countries up to 2015. <em>Ann Oncol</em> 2003; 14: 1148-1152.</p>
 <p>Salmon CA, Park KGM, Rapson T, Phull PS. Age threshold for endoscopy and the risk of missing upper GI malignancy: Data from the Scottish Audit of Gastric and Oesophageal Cancer. <em>Gut</em> 2003; 52: A26.</p>
 <p>The Scottish/Northern Irish BRCA1/BRCA2 Consortium. BRCA1 and BRCA2 mutations in Scotland and Northern Ireland. <em>Br J Cancer</em> 2003; 88: 1256-1262.</p>
 <p>Thomas E, Symmons DPM, Brewster DH, Black RJ, Macfarlane GJ. National study of cause-specific mortality in Rheumatoid Arthritis, Juvenile Chronic Arthritis, and Other Rheumatic Conditions: a 20&#8211; year follow-up study. <em>J Rheumatol</em> 2003; 30: 958-965.</p>
 <p>UK Coordinating Committee on Cancer Research (UKCCCR) Ductal Carcinoma in situ (DCIS) Working Party on behalf of DCIS trialists in the UK, Australia, and New Zealand<em>. </em>Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. <em>Lancet </em>2003; 362: 95-102.</p>
 <p><em>Willett EV, McKinney PA, Fear NT, Cartwright RA, Roman E. </em>Occupational exposure to electromagnetic fields and acute leukaemia: analysis of a case-control study.<em>Occup Environ Med</em> 2003; 60: 577-583.</p>
 <p>Wong NACS, Rae F, Herriot M, Mayer NJ, Brewster DH, Harrison DJ. SV40 Tag DNA sequences, present in a small proportion of human hepatocellular carcinomas, are associated with reduced survival. <em>J Clin Pathol</em> 2003; 56: 904-909.</p>
 <p>Wong NACS, Young R, Malcomson RDG, Nayar AG, Jamieson L, Han C, Save VE, Carey F, Brewster D, Al-Nafussi A. Prognostic indicators for gastrointestinal stromal tumors: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. <em>Histopathology</em> 2003; 43: 118-126.</p>
 <p>Wood R, Brewster DH, Fraser LA, Brown H, Hayes PC, Garden OJ. Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. <em>Eur J Cancer 2003</em>; 39: 2087-2092.</p>
 <p>Wood R, Fraser LA, Brewster DH, Garden OJ. Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968-1998. <em>Eur J Cancer </em>2003; 39: 2080-2086. </p>
 <p><strong>2004</strong></p>
<p>Brewster DH, Fordyce A, Black RJ, and the Scottish Clinical Geneticists. Impact of a cancer registry-based genealogy service to support clinical genetics services<em>. Fam Cancer</em> 2004; 3: 139-141.</p>
 <p>Clark AJ, Stockton D, Elder A, Wilson RG, Dunlop MG. Assessment of outcomes after colorectal cancer resection in the elderly as a rationale for screening and early detection. <em>Br J Surgery</em> 2004; 91: 1345-1351.</p>
 <p>Leonard RC, Lind M, Twelves C, Coleman R, van Belle S, Wilson C, Ledermann J, Kennedy I, Barrett-Lee P, Perren T, Verrill M, Cameron D, Foster E, Yellowlees A, Crown J; Anglo-Celtic Cooperative Oncology Group. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial. <em>J Natl Cancer Inst</em> 2004; 96: 1076-1083. </p>
 <p>McCallum M, Baker C, Gillespie K, Cohen B, Stewart H, Leonard R, Cameron D, Leake R, Paxton&nbsp;J, Robertson A, Purdie&nbsp;C, Gould A, Steel M. A prognostic index for operable, node-negative breast cancer. <em>Br J Cancer</em> 2004: 90; 1933-1941.</p>
 <p>Mitchell RJ, Brewster D, Campbell H, Porteous MEM, Wyllie AH, Bird CC, Dunlop MG. Accuracy of reporting of family history of colorectal cancer. <em>Gut</em> 2004; 53: 291-295.</p>
 <p>Mould R, Lahanas M, Asselain B, Brewster D, Burgers S, Damhuis R, De Rycke Y, Gennaro V, Szeszenia-Dabrowska N. Methodology for lognormal modelling of malignant pleural mesothelioma survival time distributions: a study of 5580 case histories from Europe and USA. <em>Phys Med Biol</em> 2004; 49: 3991-4004.</p>
 <p>Murchison JT, Wylie L, Stockton DL. Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study. <em>Br J Cancer </em>2004; 91: 92-95.</p>
 <p>Parks RW, Bettschart V, Frame S, Stockton DL, Brewster DH, Garden OJ. Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study. <em>Br J Cancer</em> 2004; 91: 459-465.</p>
 <p>Stark C, Hopkins P, Gibbs D, Rapson T, Belbin A, Hay A. Trends in suicide in Scotland 1981 - 1999: age, method and geography. <em>BMC Public Health</em> 2004; 4: 49.</p>
 <p>Thompson AM, Rapson T, Gilbert FJ, Park KG. Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients. <em>Surg Endosc</em> 2004; 18: 1257-1262.</p>
 <p>Thomson CS, Brewster DH, Dewar JA, Twelves CJ on behalf of the Scottish Cancer Therapy Network. Improvement in survival for women with breast cancer in Scotland between 1987 and 1993: Impact of earlier diagnosis and changes in treatment. <em>Eur J Cancer</em> 2004; 40: 743-753.</p>
 <p><strong>2005</strong></p>
<p>Black R. Ensuring high-quality epidemiological data on cancer. <em>Eur J Cancer Prev</em> 2005; 14: 305-306.</p>
 <p>Brennan P, Sc&#233;lo G, Hemminki K, Mellemkjaer L, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Seow A, Pompe-Kirn V, Martos C, Jonasson JG, Colin D, Boffetta P. Second primary cancers among 109,000 cases of non-Hodgkin lymphoma. <em>Br J Cancer</em> 2005; 93: 159-166.</p>
 <p>Brewster DH, Coebergh JW, Storm HH. Population-based cancer registries: the invisible key to cancer control. <em>Lancet Oncol</em> 2005; 6: 193-195.</p>
 <p>Brewster DH, Stockton DL, Dobbie R, Bull D, Beral V. Risk of breast cancer following miscarriage or induced abortion: a Scottish record linkage case-control study. <em>J Epidemiol Community Health </em>2005; 59: 283-287.</p>
 <p>Evans TR, Yellowlees A, Foster E, Earl H, Cameron DA, Hutcheon AW, Coleman RE, Perren T, Gallagher CJ, Quigley M, Crown J, Jones AL, Highley M, Leonard RC, Mansi JL. Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study. <em>J Clin Oncol</em> 2005; 23: 2988-2995. </p>
 <p>Hemminki K, Scelo G, Boffetta P, Mellemkjaer L, Tracey E, Andersen A, Brewster D, Pukkala E, McBride M, Kliewer E, Chia K-S, Pompe-Kirn V, Martos C, Jonasson J, Li X, Brennan P. Second primary malignancies in patients with male breast cancer. <em>Br J Cancer</em> 2005; 92: 1288-1292. </p>
 <p>Mitchell RJ, Campbell H, Farrington SM, Brewster DH, Porteous ME, Dunlop MG. Prevalence of Family History of Colorectal Cancer in the General Population. <em>Br J Surg</em> 2005; 92: 1161-1164.</p>
 <p>Murray CS, Stockton DL, Doherty VR. Thick melanoma: the challenge persists. <em>Br J Dermatol</em> 2005; 152: 104-109.</p>
 <p>Nanthakumaran S, Fernandes E, Thompson AM, Rapson T, Gilbert FJ, Park KG. Morbidity and mortality rates following gastric cancer surgery and contiguous organ removal, a population based study. <em>Eur J Surg Oncol</em> 2005; 31: 1141-1144. </p>
 <p>Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MWJ. Changing trends in incidence and mortality of thyroid cancer in Scotland. <em>Clin Endocrinol </em>2005; 62: 156-162.</p>
 <p>Storm H, Brewster DH, Coleman MP, Deapen D, Oshima A, Threlfall T, D&#233;maret E. Guidelines for confidentiality and cancer registration (letter). <em>Br J Cancer</em> 2005; 92: 2095-2096.</p>
 <p>Swerdlow AJ, Jones ME, for the British Tamoxifen Second Cancer Study Group. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. <em>J Natl Cancer Inst</em> 2005; 97: 375-384.</p>
 <p><strong>2006</strong></p>
<p>Brewster DH, Bhatti LA. Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. <em>Br J Cancer</em> 2006; 95: 87-90.</p>
 <p>Camidge DR, Stockton DL, Bain M. Factors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data. <em>Br J Cancer</em> 2006; 95: 649-652. </p>
 <p>Conway DI, Stockton DL, Warnakulasuriya KAAS, Ogden G, Macpherson LMD. Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999) - recent trends and regional variation. <em>Oral Oncol</em> 2006; 42: 586-592.</p>
 <p>Malinovszky KM, Gould A, Foster E, Cameron D, Humphreys A, Crown J, Leonard RC; Anglo Celtic Co-operative Oncology Group. Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. <em>Br J Cancer</em> 2006; 95: 1626-1631. </p>
 <p>Mellemkj&#230;r L, Friis S, Olsen JH, Sc&#233;lo G, Hemminki K, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride M, Kliewer EV, Tonita JM, Kee-Seng C, Pompe-Kirn V, Martos C, Jonasson JG, Boffetta P, Brennan P. Risk of second cancer among women with breast cancer. <em>Int J Cancer</em> 2006; 118: 2285-2292.</p>
 <p>Phull PS, Salmon CA, Park KG, Rapson T, Thompson AM, Gilbert FJ. Age threshold for endoscopy and risk of missing upper gastrointestinal malignancy - data from the Scottish audit of gastric and oesophageal cancer. <em>Aliment Pharmacol Ther</em> 2006; 23: 229-233. </p>
 <p>Poole CJ, Earl HM, Hiller L, Dunn JA, Bathers S, Grieve RJ, Spooner DA, Agrawal RK, Fernando IN, Brunt AM, O'Reilly SM, Crawford SM, Rea DW, Simmonds P, Mansi JL, Stanley A, Harvey P, McAdam K, Foster L, Leonard RC, Twelves CJ; NEAT Investigators and the SCTBG. Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. <em>N Engl J Med</em> 2006; 355: 1851-1862. </p>
 <p>Reis MM, Young D, McLeish L, Goudie D, Cook A, Sullivan F, Vysny H, Fordyce A, Black R, Tavakoli M, Steel M. Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerations. <em>Fam Cancer</em> 2006; 5: 297-303.</p>
 <p>Sandeep TC, Strachan MWJ, Reynolds RM, Brewster DH, Sc&#233;lo G, Pukkala E, Hemminki K, Andersen A, Tracey E, Friis S, McBride ML, Kee-Seng C, Pompe-Kirn V, Kliewer EV, Tonita JM, Jonasson JG, Martos C, Boffetta P, Brennan P. Second primary cancers in thyroid cancer patients: a multi-national record linkage study. <em>J Clin Endocrinol Metab</em> 2006; 91: 1819-1825.</p>
 <p>Sc&#233;lo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Andersen A, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Chia KS, Jonasson JG, Martos C, Colin D, Brennan P. Associations between small intestine cancer and other primary cancers: An international population-based study. <em>Int J Cancer</em> 2006; 118: 89-96.</p>
 <p>Shack LG, Wood HE, Kang JY, Brewster DH, Quinn MJ, Maxwell JD, Majeed A. Small intestinal cancer in England &amp; Wales and Scotland: Time trends in incidence, mortality and survival. <em>Aliment Pharmacol Ther</em> 2006; 23: 1297-1306.</p>
 <p>Shen M, Boffetta P, Olsen JH, Andersen A, Hemminki K, Pukkala E, Tracey E, Brewster DH, McBride ML, Pompe-Kirn V, Kliewer EV, Tonita JM, Chia K-S, Martos C, Jonasson JG, Colin D, Sc&#233;lo G, Brennan P. A Pooled Analysis of Second Primary Pancreatic Cancer. <em>Am J Epidemiol</em> 2006; 163: 502-511.</p>
 <p><strong>2007</strong></p>
<p>Brewster DH, Bhatti LA, Inglis JHC, Nairn ER, Doherty VR. Recent trends in incidence of non-melanoma skin cancers in the East of Scotland, 1992-2003. <em>Br J Dermatol</em> 2007; 156: 1295-1300.</p>
 <p>Brewster DH, Horner M-JD, Rowan S, Jelfs P, de Vries E, Pukkala E. Left-sided excess of invasive cutaneous melanoma in six countries. <em>Eur J Cancer</em> 2007; 43: 2634-2637.</p>
 <p>Camidge DR, Stockton DL, Frame S, Wood R, Bain M, Bateman DN. Hospital admissions and deaths relating to deliberate self-harm and accidents within 5 years of a cancer diagnosis: a national study in Scotland, UK. <em>Br J Cancer </em>2007; 96: 752-757. </p>
 <p>Conway DI, Brewster DH, McKinney PA, Stark J, McMahon AD, Macpherson LMD. Widening socio-economic inequalities in oral cancer incidence in Scotland, 1976-2002. <em>Br J Cancer</em> 2007; 96: 818-820.</p>
 <p>Engholm G, Kejs AMT, Brewster DH, Gaard M, Holmberg L, Hartley R, Iddenden R, M&#248;ller H, Sankila R, Thomson CS, Storm HH. Colorectal cancer survival in the Nordic countries and the UK. Excess mortality risk analysis of 5-year relative period survival in the period 1999-2000. <em>Int J Cancer</em> 2007; 121: 1115-1122.</p>
 <p>Erridge SC, Featherstone C, Chalmers R, Campbell J, Stockton D, Black R. What will be the radiotherapy machine capacity required for optimal delivery of radiotherapy in Scotland in 2015? <em>Eur J Cancer </em>2007; 43: 1802-1809.</p>
 <p>Erridge SC, Moller H, Price A, Brewster D. International comparisons of survival from lung cancer: pitfalls and warnings. <em>Nat Clin Pract Oncol</em> 2007; 4: 570-577.</p>
 <p>Maule M, Sc&#233;lo G, Merletti F, Brennan P, Hemminki K, Tracey E, Sankila R, Weiderpass Vainio E, Olsen JH, McBride ML, Brewster DH, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Pastore G, Boffetta P. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. <em>J Natl Cancer Inst</em> 2007; 99: 790-800.</p>
 <p>Mowbray M, Stockton DL, Doherty VR. Changes in the site distribution of malignant melanoma in South East Scotland (1979-2002). <em>Br J Cancer </em>2007; 96: 832-835.</p>
 <p>Richiardi L, Sc&#233;lo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Kee-Seng C, Jonasson JG, Martos C, Brennan P. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 Cancer Registries. <em>Int J Cancer</em> 2007; 120: 623-631.</p>
 <p>Riska A, Pukkala E, Sc&#233;lo G, Mellemkjaer L, Hemminki K, Weiderpass E, McBride ML, Pompe-Kirn V, Tracey E, Brewster DH, Kliewer EV, Tonita JM, Kee-Seng C, Jonasson JG, Martos C, Boffetta P, Brennan P. Second primary malignancies in females with primary fallopian tube cancer. <em>Int J Cancer</em> 2007; 120: 2047-2051.</p>
 <p>Sc&#233;lo G, Boffetta P, Autier A, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Chia KS, Jonasson JG, Martos C, Giblin M, Brennan P. Associations between ocular melanoma and other primary cancers: an international population-based study. <em>Int J Cancer</em> 2007; 120: 152-159.</p>
 <p>Sc&#233;lo G, Boffetta P, Corbex M, Chia K-S, Hemminki K, Friis S, Pukkala E, Weiderpass E, McBride ML, Tracey E, Brewster DH, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Brennan P. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. <em>Cancer Causes Control</em> 2007; 18: 269-278.</p>
 <p>Shack LG, Rachet B, Brewster DH, Coleman M. Socioeconomic inequalities in cancer survival in Scotland 1986-2000. <em>Br J Cancer</em> 2007; 97: 999-1004.</p>
 <p>Stark JM, Black RJ, Brewster DH. Risk of leukaemia among children living near the Solway coast of Dumfries and Galloway Health Board area, Scotland, 1975-2002. <em>Occup Environ Med</em> 2007; 64: 66-68.</p>
 <p>Thompson AM, Rapson T, Gilbert FJ, Park KG; Scottish Audit of Gastric and Oesophageal Cancer. Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. <em>Br J Surg </em>2007; 94: 578-584. </p>
 <p>Tuohimaa P, Pukkala E, Sc&#233;lo G, Olsen JH, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Kliewer EV, Pompe-Kirn V, McBride ML, Martos C, Chia K-S, Tonita JM, Jonasson JG, Boffetta P, Brennan P. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. <em>Eur J Cancer </em>2007; 43: 1701-1712.</p>
 <p>Wild SH, Bryden JR, Lee RJ, Bishop JL, Finlayson AR, Byrne CD, Brewster DH. Cancer, cardiovascular disease and diabetes mortality among women with a history of endometrial cancer. <em>Br J Cancer </em>2007; 96: 1747-1749.</p>
 <p><strong>2008</strong></p>
<p>Anandan C, Elton R, Hitchings A, Brewster DH. Nasopharyngeal Cancer Incidence and Survival in Scotland, 1975-2001. <em>Clin Otolaryngol</em> 2008; 33: 12-17.</p>
 <p>Anderson E, Berg J, Black R, Bradshaw N, Campbell J, Carnaghan H, Cetnarkyj R, Drummond S, Davidson R, Dunlop J, Fordyce A, Gibbons B, Goudie D, Gregory H, Holloway S, Longmuir M, McLeish L, Murday V, Miedzybrodska Z, Nicholson D, Pearson P, Porteous M, Reis M, Slater S, Smith K, Smyth E, Snadden L, Steel M, Stirling D, Watt C, Whyte C, Young D. Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold. <em>Br J Cancer</em> 2008; 98: 840-844.</p>
 <p>Anderson E, Berg J, Black R, Bradshaw N, Campbell J, Cetnarskyj R, Drummond S, Davidson R, Dunlop J, Fordyce A, Gibbons B, Goudie D, Gregory H, Hanning K, Holloway S, Longmuir M, McLeish L, Murday V, Miedzybrodska Z, Nicholson D, Pearson P, Porteous M, Reis M, Slater S, Smith K, Smyth E, Snadden L, Steel M, Stirling D, Watt C, Whyte C, Young D. Predicting breast cancer risk: implications of a &quot;weak&quot; family history. <em>Fam Cancer</em> 2008; 7: 361-366.</p>
 <p>Brewster DH, Stockton DL. Ascertainment of breast cancer by the Scottish Cancer Registry: An assessment based on comparison with five independent breast cancer trials databases. <em>Breast</em> 2008; 17: 106-108.</p>
 <p>Brewster DH, de Vries E. Left-Sided Excess in the Laterality of Cutaneous Melanoma (letter). <em>Arch Dermatol</em> 2008; 144: 1235.</p>
 <p>Chuang S-C, Hashibe M, Sc&#233;lo G, Brewster DH, Pukkala E, Friis S, Tracey E, Weiderpass E, Hemminki K, Tamaro S, Chia K-S, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Dresler CM, Boffetta P, Brennan P. Risk of Second Primary Cancer among Esophageal Cancer Patients: a Pooled Analysis of 13 Cancer Registries. <em>Cancer Epidemiol Biomarkers Prev</em> 2008; 17: 1543-1549.</p>
 <p>Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E, Tracey E, Friis S, Pompe-Kirn V, Brewster DH, Martos C, Chia KS, Boffetta P, Brennan P, Hashibe M. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. <em>Int J Cancer</em> 2008; 123: 2390-2396.</p>
<p>Erridge SC, Murray B, Price A, Ironside J, Little F, Mackean M, Walker W, Brewster DH, Black R, Fergusson RJ. Improved treatment and survival for lung cancer patients in South-East Scotland. <em>J Thorac Oncol</em> 2008;3: 491-498.</p>
 <p>Gondos A, Bray F, Brewster DH, Coebergh JWW, Hakulinen T, Janssen-Heijnen MLG, Kurtinaitis J, Brenner H and the EUNICE Survival Working Group. Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. <em>Eur J Cancer</em> 2008; 44: 1463-1475.</p>
 <p>Maule M, Sc&#233;lo G, Pastore G, Brennan P, Hemminki K, Pukkala E, Weiderpass E, Olsen JH, Tracey E, McBride ML, Brewster DH, Pompe-Kirn V, Tonita JM, Kliewer EV, Chia KS, Jonasson JG, Martos C, Magnani C, Boffetta P. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study. <em>Eur J Cancer</em> 2008; 44: 830-839.</p>
 <p><strong>2009</strong></p>
<p>Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP. What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? <em>Br J Cancer</em> 2009; 101 Suppl 2: S115-S124.</p>
 <p>Brewster DH, Sharpe KH, Clark DI, Collins J. Declining breast cancer incidence and decreased HRT use (letter). <em>Lancet</em> 2009; 373: 459-460.</p>
 <p>Erridge SC, Murray B, Williams L, Brewster D, Black R, Price A, Murray N, Sheehan F. Improved survival from lung cancer in British Columbia compared to Scotland &#8211;  are different treatment rates the whole story? <em>Lung Cancer</em> 2009; 64: 358-366.</p>
 <p>Erridge SC, Conkey DS, Stockton D, Strachan MW, Statham PF, Whittle IR, Grant R, Kerr GR, Gregor A. Radiotherapy for pituitary adenomas: long-term efficacy and toxicity. <em>Radiother Oncol</em> 2009; 93: 597-601. </p>
 <p>Folkesson J, Engholm G, Ehrnrooth E, Kejs AMT, P&#229;hlman L, Harling H, Wibe A, Gaard M, J&#243;nsson P, Tryggvadottir L, Brewster DH, Hakulinen T, Storm HH. Rectal Cancer Survival in the Nordic Countries and Scotland. <em>Int J Cancer</em> 2009; 125: 2406-12.</p>
 <p>Gondos A, Holleczek B, Janssen-Heijnen M, Brewster DH, Bray F, Rosso S, Hakulinen T, Brenner H and the EUNICE Survival Working Group. Model-based projections for deriving up-to-date cancer survival estimates: an international evaluation. <em>Int J Cancer</em> 2009; 125: 2666-72.</p>
 <p>Jones A, Stockton DL, Simpson AJ, Murchison JT. Idiopathic venous thromboembolic disease is associated with a poorer prognosis from subsequent malignancy. <em>Br J Cancer</em> 2009; 101: 840-842.</p>
 <p>Maddams J, Brewster D, Gavin A, Steward J, Elliott J, Utley M, M&#248;ller H. Cancer prevalence in the United Kingdom: estimates for 2008. <em>Br J Cancer</em> 2009; 101: 541-547.</p>
 <p>Steele RJ, McClements PL, Libby G, Black R, Morton C, Birrell J, Mowat NA, Wilson JA, Kenicer M, Carey FA, Fraser CG. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. <em>Gut</em> 2009; 58: 530-535.</p>
 <p><strong>2010</strong></p>
<p>Bhopal R, Fischbacher C, Povey C, Chalmers J, Mueller G, Steiner M, Brown H, Brewster DH, Bansal N. Cohort profile: Scottish Health and Ethnicity Linkage Study of 4.65 million people exploring ethnic variations in disease in Scotland. <em>Int J Epidemiol</em> 2010 Jul 24. [Epub ahead of print] </p>
 <p>Brewster DH, Tucker JS, Fleming M, Morris C, Stockton DL, Lloyd DJ, Bhattacharya S, Chalmers JWT. Risk of Skin Cancer after Phototherapy for Neonatal Jaundice: Retrospective Cohort Study. <em>Arch Dis Child </em>2010; 95: 826-831.</p>
 <p>Brewster DH, Black RJ. Survival is multifactorial (letter). <em>BMJ</em> 2010; 341: c5133.</p>
 <p>Chuang SC, Sc&#233;lo G, Lee YC, Friis S, Pukkala E, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Tamaro S, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Boffetta P, Brennan P, Hashibe M. Risks of second primary cancer among patients with major histological types of lung cancers in both men and women. <em>Br J Cancer</em> 2010; 102: 1190-1195.</p>
 <p>Conway DI, McMahon AD, Smith K, Black R, Robertson G, Devine J, McKinney PA. Components of socioeconomic risk associated with head and neck cancer: a population-based case-control study in Scotland. <em>Br J Oral Maxillofac Surg</em> 2010; 48: 11-17.</p>
 <p>Cuschieri K, Brewster DH, Williams AR, Millan D, Murray G, Nicoll S, Imrie J, Hardie A, Graham C, Cubie HA. Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines. <em>Br J Cancer</em> 2010; 102: 930-932.</p>
 <p>Doherty VR, Brewster DH, Jensen S, Gorman D. Trends in skin cancer incidence by socioeconomic position in Scotland, 1978-2004. <em>Br J Cancer </em>2010; 102: 1661-1664<em>.</em></p>
 <p>Janssen-Heijnen MLG, Gondos A, Bray F, Hakulinen T, Brewster DH, Brenner H, Coebergh JWW. Clinical Relevance of Conditional Survival of Cancer Patients in Europe: Age-Specific Analyses of 13 Cancers. <em>J Clin Oncol </em>2010; 28: 2520-2528.</p>
 <p>Junor EJ, Kerr GR, Brewster DH. Oropharyngeal cancer. Fastest increasing cancer in Scotland, especially in men (letter). <em>BMJ</em> 2010; 340:c2512.</p>
 <p>Lawder R, Harding O, Stockton D, Fischbacher C, Brewster DH, Chalmers J, Finlayson A, Conway DI. Is the Scottish population living dangerously? Prevalence of multiple risk factors: the Scottish Health Survey 2003. <em>BMC Public Health</em> 2010 Jun 11; 10: 330.</p>
 <p>Mansi JL, Yellowlees A, Lipscombe J, Earl HM, Cameron DA, Coleman RE, Perren T, Gallagher CJ, Quigley M, Crown J, Jones AL, Highley M, Leonard RC, Evans TR. Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study. <em>Breast Cancer Res Treat </em>2010; 122: 787-94.</p>
 <p>Rosso S, Gondos A, Zanetti R, Bray F, Zakelj M, Zagar T, Smailyte G, Ponti A, Brewster DH, Voogd AC, Crocetti E, Brenner H; the EUNICE Survival Working Group. Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: The role of screening and a comparison with data from the United States. <em>Eur J Cancer </em>2010; 46: 3351-7.</p>
 <p>Sharpe KH, McClements P, Clark DI, Collins J, Springbett A, Brewster DH. Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy. <em>Eur J Cancer</em> 2010; 46: 937-943.</p>
 <p>Skipworth RJE, Parks RW, Stephens NA, Graham C, Brewster DH, Garden OJ, Paterson-Brown S. The relationship between hospital volume and post-operative mortality rates for upper gastrointestinal cancer resections: Scotland 1982-2003. <em>Eur J Surg Oncol</em> 2010; 36: 141-147.</p>
 <p>Steele RJ, Kostourou I, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser C. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. <em>J Med Screen</em> 2010; 17: 68-74.</p>
 <p>Steele RJ, Kostourou I, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser C. Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening. <em>BMJ</em> 2010; 341: c5531.</p>
 <p>Woods LM, Rachet B, Shack L, Catney D, Walsh PM, Cooper N, White C, Mak V, Steward J, Comber H, Gavin A, Brewster D, Quinn M, Coleman MP. Survival from twenty adult cancers in the UK and Republic of Ireland in the late twentieth century. <em>Health Stat Q</em> 2010; 46: 7-26.</p>
 <p><strong>2011</strong></p>
<p>Bosetti C, Scelo G, Chuang SC, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E, Tracey E, Olsen JH, Pompe-Kirn V, Brewster DH, Martos C, Chia KS, Brennan P, Hashibe M, Levi F, La Vecchia C, Boffetta P. High constant incidence rates of second primary cancers of the head and neck: A pooled analysis of 13 cancer registries. <em>Int J Cancer</em> 2011; 129: 173-9.</p>
 <p>Brewster DH, Clark DI, Stockton DL, Munro AJ, Steele RJ. Characteristics of patients dying within 30 days of diagnosis of breast or colorectal cancer in Scotland, 2003-2007. <em>Br J Cancer</em> 2011; 104: 60-67.</p>
 <p>Maule M, Sc&#233;lo G, Pastore G, Brennan P, Hemminki K, Olsen JH, Tracey E, Pukkala E, Weiderpass E, Brewster DH, Tamaro S, Chia KS, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Merletti F, Boffetta P. Second malignancies after childhood non-central nervous system solid cancer: Results from 13 cancer registries. <em>Int J Cancer</em> 2011 Apr 25. doi: 10.1002/ijc.26135. [Epub ahead of print]</p>
 <p>Oliphant R, Brewster DH, Morrison DS. The changing association between socioeconomic circumstances and the incidence of colorectal cancer: a population-based study. <em>Br J Cancer</em> 2011; 104: 1791-6.
 </p>





      <!-- /Content -->
    </div>
  </div>

<!-- #include virtual = "/_inc/foot.asp" -->